Judgment of the General Court (Sixth Chamber, extended composition) of 1 July 2010.
AstraZeneca AB and AstraZeneca plc v European Commission.
Competition - Abuse of dominant position - Market in anti-ulcer medicines - Decision finding an infringement of Article 82 EC - Market definition - Significant competitive constraints - Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products - Misleading representations - Deregistration of marketing authorisations - Obstacles to the marketing of generic medicinal products and to parallel imports - Fines.
Reports of Cases
Links to the texts